Assessment of Patterns of Potentially Unsafe Use of Zolpidem
- PMID: 30014137
- PMCID: PMC6583219
- DOI: 10.1001/jamainternmed.2018.3031
Assessment of Patterns of Potentially Unsafe Use of Zolpidem
Abstract
This study evaluates data from the US Medical Expenditure Panel Survey to determine the extent of unsafe use of zolpidem.
Conflict of interest statement
Similar articles
-
Benefits of switching to suvorexant for mild primary insomnia when sleepwalking episodes occur during zolpidem treatment.Asian J Psychiatr. 2017 Dec;30:122-123. doi: 10.1016/j.ajp.2017.08.022. Epub 2017 Sep 1. Asian J Psychiatr. 2017. PMID: 28898806 No abstract available.
-
Zolpidem related persistent genital arousal disorder: An interesting case.Psychiatriki. 2019 Oct-Dec;30(4):339-344. doi: 10.22365/jpsych.2019.304.339. Psychiatriki. 2019. PMID: 32283537
-
Higher-dose uses of zolpidem will increase the subsequent risk of developing benign brain tumors.J Neuropsychiatry Clin Neurosci. 2015;27(2):e107-11. doi: 10.1176/appi.neuropsych.14010006. Epub 2014 Dec 12. J Neuropsychiatry Clin Neurosci. 2015. PMID: 25923854
-
Improved Arousal and Motor Function Using Zolpidem in a Patient With Space-Occupying Intracranial Lesions: A Case Report.PM R. 2017 Aug;9(8):831-833. doi: 10.1016/j.pmrj.2016.12.011. Epub 2017 Jan 16. PM R. 2017. PMID: 28093373 Review.
-
Low-dose sublingual zolpidem (Intermezzo) for insomnia due to middle-of-the-night awakening.Med Lett Drugs Ther. 2012 Apr 2;54(1387):25-6. Med Lett Drugs Ther. 2012. PMID: 22469649 Review. No abstract available.
Cited by
-
Development of a Web Application for Simulating Plasma Drug Concentrations in Patients with Zolpidem Intoxication.Pharmaceutics. 2024 May 20;16(5):689. doi: 10.3390/pharmaceutics16050689. Pharmaceutics. 2024. PMID: 38794351 Free PMC article.
-
A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists.J Clin Sleep Med. 2024 Apr 1;20(4):603-613. doi: 10.5664/jcsm.10946. J Clin Sleep Med. 2024. PMID: 38063235
-
Abusive use of Zolpidem as a Result of COVID-19 and Perspectives of Continuity of the Problem in the Post-Pandemic Period.Curr Neuropharmacol. 2024;22(10):1578-1582. doi: 10.2174/1570159X21666230920123401. Curr Neuropharmacol. 2024. PMID: 37811654 Free PMC article. Review.
-
Trends in the Use of Benzodiazepines, Z-Hypnotics, and Serotonergic Drugs Among US Women and Men Before and During the COVID-19 Pandemic.JAMA Netw Open. 2021 Oct 1;4(10):e2131012. doi: 10.1001/jamanetworkopen.2021.31012. JAMA Netw Open. 2021. PMID: 34694388 Free PMC article.
-
The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial.Neuropsychopharmacology. 2022 Jan;47(2):570-579. doi: 10.1038/s41386-021-01191-3. Epub 2021 Oct 11. Neuropsychopharmacology. 2022. PMID: 34635802 Free PMC article. Clinical Trial.
References
-
- AMBIEN—Zolpidem Tartrate Tablet [package insert]. Bridgewater, NJ: Sanofi-Aventis US, LLC; 2014.
-
- FDA Drug Safety Communication FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR. Published May 14, 2013. https://www.fda.gov/Drugs/DrugSafety/ucm352085.htm. Accessed March 8, 2018.
-
- AHRQ Agency for Healthcare Research and Quality Medical Expenditure Panel Survey. https://www.meps.ahrq.gov/mepsweb/. Accessed March 15, 2018.
-
- Moore TJ, Furberg CD, Mattison DR, Cohen MR QuarterWatch 2014, Quarter 2: New Safety Perspectives. Institute for Safe Medication Practices. Published May 6, 2015. https://www.ismp.org/sites/default/files/attachments/2018-01/2014Q2_0.pdf. Accessed March 8, 2018.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
